Last Updated：2025/11/28
Sentence
臨床試験で、5-HT2A受容体およびα1アドレナリン受容体を同時に拮抗する薬（高血圧治療薬として開発されたが市販されなかった）は、これらの受容体に対して強力な拮抗作用を示した。
Quizzes for review
In the clinical study, lidanserin showed potent antagonism at 5-HT2A and α1-adrenergic receptors but was never marketed as an antihypertensive.
See correct answer
In the clinical study, lidanserin showed potent antagonism at 5-HT2A and α1-adrenergic receptors but was never marketed as an antihypertensive.
音声機能が動作しない場合はこちらをご確認ください
English - English
Word Edit Setting
- Users who have edit permission for words - All Users
- Screen new word creation
- Screen word edits
- Screen word deletion
- Screen the creation of new headword that may be duplicates
- Screen changing entry name
- Users authorized to vote on judging - Editor
- Number of votes required for decision - 1
Sentence Edit Setting
- Users who have edit permission for sentences - All Users
- Screen sentence deletion
- Users authorized to vote on judging - Editor
- Number of votes required for decision - 1
Quiz Edit Setting
- Users who have edit permission for quizzes - All Users
- Users authorized to vote on judging - Editor
- Number of votes required for decision - 1
